FORMAN MARK S (Chief Medical Officer) sold 3.3% of their position (1.64K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $1.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−1.64K
Price / share
$0.97
Trade value
$1.59K
% of position
Net shares
+3.36K
Net value
-$1.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2024 | M · Option Exercise | +5K | — | — | 11.0% | 45.27K | 50.27K |
| Common Stock Direct | 2/13/2024 | S · Sale | −1.64K | $0.97 | $1.59K | 3.3% | 50.27K | 48.63K |
| Total | +3.36K | -$1.59K | ||||||
Employee Stock Option (right to buy)
Common Stock
130K shares
Shares
+130K
Strike price
10.84
Held after
130K
Exercisable
—
Employee Stock Option (right to buy)
Common Stock
25K shares
Shares
+25K
Strike price
4.52
Held after
25K
Exercisable
—
Restricted Stock Unit
Common Stock
15K shares
Shares
+15K
Strike price
Held after
15K
Exercisable
—
Restricted Stock Unit
Common Stock
5K shares
Shares
−5K
Strike price
Held after
10K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock130K shares | 8/16/2021 | A · Award | +130K | 10.84 | — | 130K |
| Employee Stock Option (right to buy) Direct | Common Stock25K shares | 2/10/2022 | A · Award | +25K | 4.52 | — | 25K |
| Restricted Stock Unit Direct | Common Stock15K shares | 2/10/2022 | A · Award | +15K | — | 15K | |
| Restricted Stock Unit Direct | Common Stock5K shares | 2/10/2024 | M · Option Exercise | −5K | — | 10K |